On Thursday, Evotec SE (NASDAQ:EVO) entered a technology development partnership with Novo Nordisk A/S (NYSE:NVO) in cell therapy. Evotec and Novo Nordisk have significant expertise and a strategic ...
Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalities. Investment enables ten new J.MD ™ projects encompassing molecular optimizatio ...
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results